EB-1020

Phase 3Small molecule

Otsuka

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Attention Deficit Hyperactivity Disorder (ADHD)Recruiting

Attention Deficit Hyperactivity Disorder (ADHD)Phase 3

Recruiting

Timeline

Expected Milestones

Q4 2027

PreclinicalRecruiting

Attention Deficit Hyperactivity Disorder (ADHD)

NCT06931080

Phase 3Recruiting

Attention Deficit Hyperactivity Disorder (ADHD)

NCT06926829

Clinical

Trials by Indication[1]

Attention Deficit Hyperactivity Disorder (ADHD)2 trials

A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-controlled, Trial to Evaluate the Efficacy and Safety of EB-1020 Once Daily QD XR Capsules Administered Orally at Low or High Dose in Adults With Attention-deficit/Hyperactivity Disorder

Recruiting· Otsuka logo

Otsuka·Preclinical·NCT06931080·630 enrolled

A Phase 3, Multicenter, Open-label, Uncontrolled, Long-term Trial to Evaluate the Safety and Efficacy of Long-term Administration of EB-1020 Once Daily QD XR Capsules in Adults With Attention-deficit/Hyperactivity Disorder

Recruiting· Otsuka logo

Otsuka·Phase 3·NCT06926829·180 enrolled

Tolerance1 trial

A Study to Evaluate the Safety, Tolerance, and Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation of EB-1020

Completed·NNeurovance, Inc.·Phase 1·NCT01744808·54 enrolled

Abuse Potential1 trial

A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users

Completed·NNeurovance, Inc.·Phase 1·NCT02144415·80 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for EB-1020. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — EB-1020 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for EB-1020. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Otsuka company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Otsuka